TrialJournal of neurology, neurosurgery, and psychiatry2019

Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study.

Ryuji Kaji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.